Inducer of phase ii enzymes. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Liver Microsomes, Liver Cell Line Hepatocytes Cells, Cultured Lung

Organisms6

Brassica Rats, Inbred F344 Rats, Sprague-Dawley Escherichia coli Coxiella Coxiella burnetii

Diseases39

Lung Neoplasms Neutropenia Neoplasm Metastasis Leukopenia Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Disease Progression Nausea Neoplasms Thrombocytopenia Liver Neoplasms, Experimental Breast Neoplasms Brain Neoplasms Hematologic Diseases Colorectal Neoplasms Peritoneal Neoplasms Ovarian Neoplasms Melanoma Stomach Neoplasms Vomiting Biliary Tract Neoplasms Kidney Neoplasms Carcinoma, Squamous Cell Liver Neoplasms Asthenia Carcinoma, Renal Cell Pancreatic Neoplasms Sarcoma Carcinoma, Small Cell Prostatic Neoplasms Head and Neck Neoplasms Urologic Neoplasms Pleural Neoplasms Glioblastoma Q Fever Fatigue Diarrhea Carcinoma Mesothelioma

Chemicals and Drugs99

NAD(P)H Dehydrogenase (Quinone)Glutathione Transferase Isothiocyanates Glucuronosyltransferase Thiocyanates Anticarcinogenic Agents NF-E2-Related Factor 2 Xenobiotics Glucosinolates Cytochrome P-450 Enzyme System Cytochrome P-450 CYP1A1 Glutathione Reductase Heme Oxygenase-1 Cytochrome P-450 CYP1A2 Enzymes Glutathione S-Transferase pi Sulfotransferases Carcinogens Glucuronides Antioxidants Glutathione Peroxidase Vehicle Emissions Plant Extracts RNA, Messenger Glutathione Isoenzymes Antineoplastic Agents Deoxycytidine DNA Topoisomerases, Type II Paclitaxel Taxoids Cisplatin Fluorouracil Camptothecin Organoplatinum Compounds Antineoplastic Agents, Phytogenic Interferon Inducers Carboplatin Topoisomerase II Inhibitors Antibodies, Monoclonal, Humanized Benzo(a)pyrene Glutamate-Cysteine Ligase Allyl Compounds Cytochrome P-450 CYP2B1 Recombinant Proteins Antimetabolites, Antineoplastic Electron Transport Complex II Vinblastine Aryl Hydrocarbon Hydroxylases DNA Adducts Quinazolines Dacarbazine Epoxide Hydrolases Leucovorin Antibodies, Monoclonal Antineoplastic Agents, Alkylating Doxorubicin Epothilones Benzenesulfonates Tegafur Flavonoids Phenylurea Compounds Etoposide DNA Phenols Niacinamide Oxonic Acid Enzyme Inhibitors DNA, Superhelical Phospholipases A2 Phospholipases A Ifosfamide Antigens, CD147 Epirubicin DNA Primers Cyclophosphamide Bacterial Proteins DNA-Binding Proteins Estramustine Pyridines Pyrazines Angiogenesis Inhibitors Bridged Compounds Thalidomide Depsipeptides Guanine Antibiotics, Antineoplastic Vincristine Protein Kinase Inhibitors Dexamethasone Anthracyclines Indoles Pyrroles Granulocyte Colony-Stimulating Factor Isopropyl Thiogalactoside Antibodies, Monoclonal, Murine-Derived Boronic Acids Pyrimidines beta-Naphthoflavone

Analytical, Diagnostic and Therapeutic Techniques and Equipment39

Clinical Trials, Phase II as Topic Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Disease-Free Survival Drug Evaluation Survival Analysis Maximum Tolerated Dose Survival Rate Administration, Oral Neoplasm Staging Clinical Trials, Phase III as Topic Combined Modality Therapy Salvage Therapy Cloning, Molecular Liver Neoplasms, Experimental Kaplan-Meier Estimate Remission Induction Endpoint Determination Neoadjuvant Therapy Clinical Trials, Phase I as Topic Mass Spectrometry Chromatography, High Pressure Liquid Reverse Transcriptase Polymerase Chain Reaction Research Design Feasibility Studies Sequence Alignment Follow-Up Studies Models, Molecular Area Under Curve Chemotherapy, Adjuvant Chromatography, Ion Exchange Double-Blind Method Clinical Trials as Topic Prospective Studies Prognosis Treatment Failure Electrophoresis, Polyacrylamide Gel

Phenomena and Processes37

Metabolic Detoxication, Phase II Metabolic Detoxication, Drug Enzyme Induction Metabolic Detoxication, Phase I Gene Expression Regulation, Enzymologic Biotransformation Diet Oxidative Stress Dose-Response Relationship, Drug Maximum Tolerated Dose Base Sequence Amino Acid Sequence DNA Cleavage Kinetics Substrate Specificity DNA Adducts Time Factors Drug Resistance, Neoplasm Mutation Transcription, Genetic Sequence Homology, Amino Acid DNA, Superhelical Gene Expression Molecular Structure Molecular Weight Organ Specificity Plasmids Area Under Curve Binding Sites Catalysis Species Specificity Protein Binding Hydrolysis Apoptosis Protein Conformation Protein Structure, Tertiary Polymorphism, Genetic

Disciplines and Occupations1

Research Design

Technology, Industry, Agriculture1

Information Science4

Molecular Sequence Data Survival Rate Base Sequence Amino Acid Sequence

Health Care15

Clinical Trials, Phase II as Topic Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Clinical Trials, Phase III as Topic Kaplan-Meier Estimate Clinical Trials, Phase I as Topic Feasibility Studies Follow-Up Studies Area Under Curve Double-Blind Method Clinical Trials as Topic Prospective Studies Treatment Failure

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Metabolic Detoxication, Phase II NAD(P)H Dehydrogenase (Quinone)Glutathione Transferase Metabolic Detoxication, Drug Isothiocyanates Glucuronosyltransferase Thiocyanates Enzyme Induction Anticarcinogenic Agents NF-E2-Related Factor 2 Xenobiotics Metabolic Detoxication, Phase I Brassica Clinical Trials, Phase II as Topic Glucosinolates Cytochrome P-450 Enzyme System Liver Cytochrome P-450 CYP1A1 Glutathione Reductase Heme Oxygenase-1 Cytochrome P-450 CYP1A2 Enzymes Microsomes, Liver Glutathione S-Transferase pi Sulfotransferases Gene Expression Regulation, Enzymologic Carcinogens Glucuronides Antioxidants Biotransformation Rats, Inbred F344 Glutathione Peroxidase Vehicle Emissions Plant Extracts RNA, Messenger Glutathione Isoenzymes Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Diet Oxidative Stress Rats, Sprague-Dawley Infusions, Intravenous Antineoplastic Agents Deoxycytidine DNA Topoisomerases, Type II Disease-Free Survival Paclitaxel Dose-Response Relationship, Drug Taxoids Drug Evaluation Cisplatin Fluorouracil Survival Analysis Molecular Sequence Data Camptothecin Organoplatinum Compounds Antineoplastic Agents, Phytogenic Lung Neoplasms Maximum Tolerated Dose Interferon Inducers Survival Rate Neutropenia Neoplasm Metastasis Carboplatin Topoisomerase II Inhibitors Leukopenia Neoplasm Recurrence, Local Base Sequence Amino Acid Sequence Administration, Oral Antibodies, Monoclonal, Humanized Benzo(a)pyrene DNA Cleavage Glutamate-Cysteine Ligase Allyl Compounds Kinetics Cytochrome P-450 CYP2B1 Recombinant Proteins Antimetabolites, Antineoplastic Neoplasm Staging Clinical Trials, Phase III as Topic Electron Transport Complex II Substrate Specificity Combined Modality Therapy Carcinoma, Non-Small-Cell Lung Salvage Therapy Disease Progression Vinblastine Aryl Hydrocarbon Hydroxylases DNA Adducts Quinazolines Dacarbazine Nausea Epoxide Hydrolases Neoplasms Leucovorin Antibodies, Monoclonal Cell Line

No FAQ available that match "inducer of phase ii enzymes"